We were delighted to welcome Rob Koremans , CEO, Luigi La Corte, CFO and Erdem Cinar, our VP in manufacturing Opalia Recordati site.

The main objective of the visit was to strengthen relations and strategy within the group, implement the Group’s strategy of combining organic growth of the current portfolio with value enhancing Business Development, driving growth and business performance in our company.

Patients are at the heart of our mission, and under Rob’s leadership Recordati will continue to be committed to care about people and cure with afordable and high quality medicines.”